Drug intelligence / Profile preview

CP1 Formula

Development stage
Unknown
Lead developer
Finch Therapeutics Group
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

CP1 Formula, also known as Custom Probiotics CP-1 Adult Formula, is a premium probiotic dietary supplement designed to support gut health and overall well-being. It contains five superior strains of acid-resistant, freeze-dried probiotic microorganisms: Lactobacillus acidophilus (Strain LA-14), Lactobacillus rhamnosus (Strain LR-32), Lactobacillus plantarum (Strain LP-115), Bifidobacterium lactis (Strain BL-04), and Bifidobacterium bifidum (Strain Bb-06). Each capsule provides a high bacterial count, typically 60 billion CFU at the time of expiration. The formulation is dairy-free, hypoallergenic, and free from artificial colors, flavors, preservatives, sugar, gluten, soy, casein, yeast, FOS, and genetically modified organisms. It aims to maintain a balanced intestinal microflora, improve digestive processes, and enhance immune response.

Brand names
CP1 FormulaCP-1 FormulaCP 1 FormulaCustom Probiotics CP-1Adult Formula CP-1

Beyond the preview

Go deeper on CP1 Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CP1 Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call